Philippe Moreau - Researcher Profile

Publications

2 shown

Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myeloma

Philippe Moreau , Federica Cavallo , Xavier Leleu +7 more

2011 Leukemia 56 citations

Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

Nikhil C. Munshi , Larry D. Anderson , Nina Shah +25 more

Ide-cel induced responses in a majority of heavily pretreated patients with refractory and relapsed myeloma; MRD-negative status was achieved in 26% of treated patients. Almost ...

2021 New England Journal of Medicine 2137 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 2,193
Institution: Centre Hospitalier Universitaire de Nantes

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-1780-8746

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.